Back to search

Article

Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study

2022-03-10

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> SARS-CoV-2 vaccination of persons aged 12 years and older has reduced disease burden in the United States. The COVID-19 Scenario Modeling Hub convened multiple modeling teams in September 2021 to project the impact of expanding vaccine administration to children 5-11 years old on anticipated COVID-19 burden and resilience against variant strains. <h4>Methods</h4> Nine modeling...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
831afc8f-aeac-5328-b363-6d94b278201a
DOI
10.1101/2022.03.08.22271905
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studyDOI 10.1101/2022.03.08.22271905
Forecasting the Trajectory of the COVID-19 Pandemic under Plausible Variant and Intervention Scenarios: A Global Modelling StudySemantic proximity
Projecting the transition of COVID-19 burden towards the young population while vaccines are rolled out: a modelling studySemantic proximity
Projecting the Transition of COVID-19 Burden Towards the Young Population While Vaccines are Rolled Out: A Modelling StudySemantic proximity
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity
Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United StatesSemantic proximity
Changing impact of COVID-19 vaccination on COVID-19 mortality in the SARS-CoV-2 omicron variant period, 2022-2025Semantic proximity
Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, December 2021 - May 2022Semantic proximity
Variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021Semantic proximity
Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity
The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United StatesSemantic proximity
Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationSemantic proximity
Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity
Select a neighboring publication to make it the new centre.